Skip to main content
SpringerLink
Log in

Antipoliomyelitis neutralizing antibodies in material and neonatal serum

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

During 1993 blood samples were taken from 1251 women consecutively admitted to the Maternity Ward of the University of Parma. Samples were also taken from all the newborn babies. Absence of antipolio neutralizing antibodies in serum diluted 1/2 was shown in 6 mothers; 4 mothers for polio 1, 1 mother for polio 2 and 1 simultaneously for the poliovirus 1 and 3. If one considers only the cases of absence in undiluted serum, there were 2 negative subjects (0.16%). One of these was for antibodies against polio 1 and the other for antibodies against polio 2. In the cord blood samples the frequency of negative results in serum diluted 1/2 is higher: 42 in all with 13 babies negative for polio 1, 17 babies for polio 2, 8 for polio 3 and 2 babies simultaneously for polio 1 and polio 3. If one considers just the babies without antibodies even in undiluted serum, the fraction of seronegatives is 9 (0.7%) with 1 for polio 1, 6 for polio 2 and 1 for types 1 and 3. The Geometric Mean Titres of the antibodies are significantly higher in mothers born before 1964 (year of introduction of mass vaccination with OPV) compared with those born after that year. Likewise, the same phenomenon was observed in the respective children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Expanded Programme on Immunization: Poliomyelitis outbreak. Wkly Epidemiol Rec 1992; 67: 341–348.

    Google Scholar 

  2. Oostvogel PM, van Wijngaarden JK, van der Avoort HGAM, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93. Lancet 1994; 344: 665–670.

    Google Scholar 

  3. Slater PE, Orenstein WA, Morag A. Poliomyelitis outbreak in Israel in 1988: A report with two commentaries. Lancet 1990; 5: 1192–1196.

    Google Scholar 

  4. World Health Organization. Expanded Programme on Immunization, Poliomyelitis in 1991. Wkly Epidemiol Rec 1993; 68: 17–24.

    Google Scholar 

  5. CDC. Progress toward global poliomyelitis eradication, 1985–1994. Morb Mort Wkly Rep 1995; 44: 273–281.

    Google Scholar 

  6. World Health Organization. Poliomyelitis outbreak, Albania. Wkly Epidemiol Rec 1996; 39: 293–295.

    Google Scholar 

  7. World Health Organization. Expanded Programme on Immunization, Progress towards poliomyelitis eradication, 1994. Wkly Epidemiol Rec 1995; 70: 97–104.

    Google Scholar 

  8. Maciocco G, Valsecchi M. Le malattie infettive. In: Geddes M (eds), La salute degli italiani: Rapporto 1993. Roma: La Nuova Italia Scientifica, 1994: 163–177.

    Google Scholar 

  9. Novello F, Lombardi F, Amato C, et al. Paralytic poliomyelitis in Italy (1981–85). Eur J Epidemiol 1987; 3: 54–60.

    Google Scholar 

  10. Grandolfo M E. ‘Poliomielite — Un problema attuale’. Giornata di Studio. Istituto Superiore di Sanità, Roma 15–10–1988.

    Google Scholar 

  11. Giovanardi A. La vaccinazione contro la poliomielite con virus vivente ed attenuato secondo Sabin: Primi risultati della campagna condotta in Italia nel 1964. Tecnica Sanitaria 1967; 2: 213–236.

    Google Scholar 

  12. Cellesi C, Rossolini A, Bianchi Bandinelli ML, et al. Stato immunitario verso la poliomielite in un campione di popolazione della provincia di Siena. Boll Microbiol Indag Lab 1985; 1: 37–41.

    Google Scholar 

  13. Albano A, Bruscolini F, Pianetti A, et al. Valutazione dell'immunità antipoliomielitica dopo circa un ventennio dall'inizio della vaccinazione per via orale. Igiene Moderna 1986; 86: 187–197.

    Google Scholar 

  14. Moschen ME, Farisano G, Bonello C, et al. Prevalence of poliovirus neutralizing antibodies: A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age. Boll Ist Sieroter Milan 1987; 66: 97–100.

    Google Scholar 

  15. La Rosa G, Intonazzo V, Lampiasi AM. Osservazioni sullo stato dell'immunità antipoliomielitica in soggetti abitanti a Palermo. Igiene Moderna 1987; 88: 203–209.

    Google Scholar 

  16. Trivello R, Renzulli G, Farisano G, et al. Persistence of poliovirus-neutralizing antibodies 2–16 years after immunization with live attenuated vaccine: A seroepidemiologic survey in the mainland of Venice. Epidemiol Inf 1988; 101: 605–609.

    Google Scholar 

  17. Fraizzoli G, Sesana BM, Profeta ML. Prevalenza degli anticorpi neutralizzanti verso il poliovirus dopo 10 e 15 anni dalla somministrazione di vaccino orale tipo Sabin. J Prev Med Hyg 1989; 30: 195–202.

    Google Scholar 

  18. Reali D, Carducci A, Ruschi MA. Serum antibodies to polioviruses in a tuscan population, Italy. Eur J Epidemiol 1990; 6: 309–312.

    Google Scholar 

  19. Squeri L, Fabiano G, Crupi D, et al. Sulla persistenza degli anticorpi antipoliomielitici in un campione di popolazione di età compresa fra 1 e 25 anni. Riv Ital Ig 1991; 3–4: 165–171.

    Google Scholar 

  20. Podda A, Bandinelli L, Giovanoni F, et al. Persistenza della protezione immunitaria nei confronti di difterite, tetano e poliomielite in una comunità di giovani adulti. 34° Congresso Nazionale S.I.T.I. Roma, 16–19 Aprile 1991.

  21. Pregliasco F, Minolfi V, Binda S, et al. Poliomielite: Vaccinazione ancora attuale. Ann Ig 1994; 6: 675–684.

    Google Scholar 

  22. Kyriazopoulou-Dalaina V. Poliovirus antibody in Northern Greece. J Hyg Cambr 1986; 96: 479–482.

    Google Scholar 

  23. White PMB, Green J. Prevalence of antibody to poliovirus in England and Wales, 1984–86. Br Med J 1986; 293: 1153–1155.

    Google Scholar 

  24. Joseph CA, Begg NT, Stanwell-Smith RE, et al. Antibody state to poliovirus in first year university students. Br Med J 1987; 295: 171–173.

    Google Scholar 

  25. Bellelli E, Bracchi U, Tanzi ML, et al. Poliomyelitis immunity status at different intervals from vaccination. Eur J Epidemiol 1986; 2: 197–204.

    Google Scholar 

  26. Bellelli E, Tanzi ML, Bocelli V, et al. Antipoliomyelitis immunity status among a population that was regularly vaccinated 11–12 years before. Eur J Epidemiol 1991; 7: 605–611.

    Google Scholar 

  27. Bodian D, Paffenbarger RS. Poliomyelitis infection in households: Frequency of viremia and specific antibody response. Am J Hyg 1954; 60: 83–99.

    Google Scholar 

  28. Salk JE, Pittisburgh MD. Antigenic potency of poliomyelitis vaccine: Influence on degree and duration of vaccine effect. JAMA 1956; 162: 1451–1459.

    Google Scholar 

  29. Fox JP. Modes of action of poliovirus vaccines and relation to resulting immunity. Rev Infec Dis 1984; 6: 352–355.

    Google Scholar 

  30. Melnick JL. Live attenuated poliovirus vaccines. In: Plotkin SA, Mortimer EA (eds), Vaccines, 2nd edn. Philadelphia: WB Saunders, 1994: 155–202.

    Google Scholar 

  31. Horstmann DM, Paul JR, Godenne-McCrea M, et al. Immunization of preschool children with Oral poliovirus vaccine (Sabin). JAMA 1961; 178: 693–701.

    Google Scholar 

  32. Sabin AB. Vaccination against poliomyelitis in economically underdeveloped countries. Bull World Health Organ 1980; 58: 141–157.

    Google Scholar 

  33. Albrecht P, van Steenis G, van Wezel AL, et al. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6(suppl 2): 540–544.

    Google Scholar 

  34. World Health Organization. Determination of neutralizing antibodies to poliovirus. In: WHO (eds), Manual for the virological investigation of poliomyelitis (WHO/EPI/CDS/POLIO/90.1). Geneve: World Health Organization, 1992: 64–72.

    Google Scholar 

  35. Hovi T. Remaining problems before eradication of poliomyelitis can be accomplished. In: Melnick JL (ed), Progress in medical virology. Basel: Karger, 1991; 38: 69–95.

    Google Scholar 

  36. Tanzi ML, Bracchi U, Bellelli E. Anticorpi neutralizzanti i tre virus poliomielitici in sieri materni e neonatali. Igiene Moderna 1984; 3: 331–346.

    Google Scholar 

  37. Tanzi ML, Bracchi U, Bocelli V, et al. Stato immunitario verso la poliomielite in un campione di popolazione delle provincie di Cremona e di Mantova. Ann Ig 1991; 3: 105–113.

    Google Scholar 

  38. Bellelli E, Tanzi ML, Bracchi U, et al. Acque reflue urbane: Monitoraggio virologico. Igiene Moderna 1996; 105: 41–54.

    Google Scholar 

  39. Tonelli E, Zanetti F, Stampi S, et al. Confronto sulla efficacia dell'ossigeno e dell'aria atmosferica negli impianti di depurazione di acque cloacali. Ann Ig 1994; 6: 945–952.

    Google Scholar 

  40. Smorodintsev AA, Davidenkova EF, Drobyshevskaya AI, et al. Results of a study of the reactogenic and immunogenic properties of live anti-poliomyelitis vaccine. Bull World Health Organ 1959; 20: 1053–1074.

    Google Scholar 

  41. Horstmann DM, James C, Niederman C, et al. Attenuated type 1 poliovirus vaccine, its capacity to infect and to spread from ‘vaccines’ within an institutional population. JAMA 1959; 170: 65–72.

    Google Scholar 

  42. Gelfand HM, Le Blanc DR, Potash L, et al. Studies on the development of natural immunity to poliomyelitis in Louisiana, IV: Natural infections with polioviruses following immunization with a formalin-inactivated vaccine. Am J Hyg 1959; 70: 312–327.

    Google Scholar 

  43. Plotkin SA, Koprowski H, Richardson SN, et al. Vaccination of families against poliomyelitis by feeding and by conctat spread of living attenuated virus. Including studies of virus properties after human intestinal passage. Acta Paed 1960; 49: 551–571.

    Google Scholar 

  44. Bodian D, Horstmann DM. Polioviruses. In: Horsfall F L, Tamm I (eds), Viral and rickettsial infections of man. Philadelphia: JB Lippincott, 1965; 430–473.

    Google Scholar 

  45. Paul JR. Endemic and epidemic trends of poliomyelitis in Central and South America. Bull World Health Organ 1958; 19: 747–758.

    Google Scholar 

  46. Fox JP, Gelfand HM, LeBlanc DR, et al. The spread vaccine strains of poliovirus in the household and in the community in southern Louisiana [Dissertation]. Philadelphia: 5th Int Polio Conf, 1961, 368–383 pp.

    Google Scholar 

  47. Brouwer R, de Groot IGM, Verheij FBM. Comparison of maternal and cord serum titres for measles and for rubella antibodies. Arch Ges Virusforsh 1974; 44: 237–242.

    Google Scholar 

  48. Gendrel D, Richard-Lenoble D, Blot Ph, et al. Transfert des immunoglobulines et des anticorps antirougeoleux de la mère à l'enfant en Afrique et en Europe. Presse Méd 1988; 17: 1633–1636.

    Google Scholar 

  49. Evans AS. The need for serologic evaluation of immunization programs. Am J Epidem 1980; 112: 725–731.

    Google Scholar 

  50. Evans AS. Criteria for assessing accomplishment of poliomyelitis control. Rew Infect Dis 1984; 6(suppl 2): 571–576.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Igiene, University of Parma, Parma, Italy

    M-L. Tanzi, M. Colotto, P. Affanni, U. Bracchi & E. Bellelli

Authors
  1. M-L. Tanzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Colotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Affanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Bracchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Bellelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanzi, ML., Colotto, M., Affanni, P. et al. Antipoliomyelitis neutralizing antibodies in material and neonatal serum. Eur J Epidemiol 13, 559–565 (1997). https://doi.org/10.1023/A:1007345930234

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007345930234

Search

Navigation